Flow cytometry as an integrative method for the evaluation of vaccine immunogenicity: A validation approach

Elena Gianchecchi1, Alessandro Torelli2, Pietro Piu1

  • 1VisMederi S.r.l., Siena, Italy.

Insights

This study presents a validated approach for flow cytometry assays to ensure reliable human immune response data in clinical trials. It addresses the need for standardized methods in evaluating vaccine immunogenicity.

Area of Science:

  • Immunology
  • Bioanalytical Sciences
  • Clinical Research

Background:

  • Reliable evaluation of human immune responses in clinical trials requires well-characterized and validated bioanalytical assays.
  • Standardization recommendations for flow cytometry exist, but definitive guidelines for clinical applications are lacking.

Purpose of the Study:

  • To provide a comprehensive validation approach for flow cytometry assays.
  • To demonstrate the applicability of validated flow cytometry for clinical research and vaccine immunogenicity evaluation.

Main Methods:

  • Validation of flow cytometry assays was performed by examining key parameters.
  • Parameters included linearity, relative accuracy, repeatability, intermediate precision, range, detection limits, and specificity.

Main Results:

  • The presented validation approach systematically assesses critical assay performance characteristics.
  • Demonstrated the suitability of flow cytometry for reliable measurement of immune responses in clinical settings.

Conclusions:

  • A robust validation strategy is essential for flow cytometry assays used in clinical research.
  • Validated flow cytometry can serve as a reliable method for assessing vaccine immunogenicity.